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Summary
Background: The ABO blood groups result from DNA sequence 
variations, predominantly single nucleotide and insertion/dele-
tion polymorphisms (SNPs and indels), in the ABO gene encod-
ing a glycosyltransferase. The ABO blood groups A1, A2, B and O 
predominantly result from the wild type allele A1 and the major 
gene variants that are characterized by four diallelic markers 
(261G>del, 802G>A, 803G>C, 1061C>del). Here, we were inter-
ested to evaluate the impact of ABO genotyping compared to 
ABO phenotyping in paternity testing. Methods: The major ABO 
alleles were determined by PCR amplification with sequence-spe-
cific primers (PCR-SSP) in a representative sample of 1,335 blood 
donors. The genotypes were compared to the ABO blood groups 
registered in the blood donor files. Then, the ABO phenotypes 
and genotypes were determined in 95 paternity trio cases that 
have been investigated by 12 short tandem repeat (STR) markers 
before. We compared statistical parameters (PL, paternity like-
lihood; PE, power of exclusion) of both blood grouping ap-
proaches. Results: The prevalence of the major ABO alleles and 
genotypes corresponded to the expected occurrence of ABO 
blood groups in a Caucasian population. The low resolution gen-
otyping of 4 diallelic markers revealed a correct genotype-pheno-
type correlation in 1,331 of 1,335 samples (99.7%). In 60 paternity 
trios with confirmed paternity of the alleged father based on STR 
analysis both PL and PE of the ABO genotype was significantly 
higher than of the ABO phenotype. In 12 of 35 exclusion cases 
(34.3%) the ABO genotype also excluded the alleged father, 
whereas the ABO phenotype excluded the alleged father only in 7 
cases (20%). Conclusion: In paternity testing ABO genotyping is 
superior to ABO phenotyping with regard to PL and PE, however, 
ABO genotyping is not sufficient for valid paternity testing. Due 
to the much lower mutation rate compared to STR markers, 
blood group SNPs in addition to anonymous SNPs could be con-
sidered for future kinship analysis and genetic identity testing.
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Zusammenfassung
Hintergrund: Die AB0-Blutgruppen basieren auf DNA-Sequenz-
Variationen – vor allem Single-Nucleotide- und Insertion/Dele-
tion-Polymorphismen (SNPs und Indels) im AB0-Gen, das eine 
Glykosyltransferase kodiert. Die AB0-Blutgruppen A1, A2, B und 0 
resultieren hauptsächlich aus dem Wildtyp-Allel A1 und den 
Haupt-Genvarianten, die durch vier diallele Marker (261G>del, 
802G>A, 803G>C, 1061C>del) charakterisiert sind. In der aktuellen 
Arbeit gilt unser Interesse der Frage, welche Bedeutung die AB0-
Genoypisierung im Vergleich zu AB0-Phänotypisierung bei der 
Vaterschaftstestung hat. Methoden: Die Haupt-AB0-Allele wurden 
mittels PCR-Amplifizierung mit sequenzspezifischen Primern 
(PCR-SSP) in einer repräsentativen Auswahl von 1335 Blut-
spendern untersucht. Die Genotypen wurden mit den in den Blut-
spenderdateien registrieren AB0-Blutgruppen verglichen. Außer-
dem wurden die AB0-Phäno- und Genotypen in 95 Vaterschafts-
Trio-Fällen, die bereits mit 12 Short-Tandem-Repeat(STR)- 
Markern untersucht worden waren, bestimmt. Die statistischen 
Parameter (PL = Vaterschaftswahrscheinlichkeit und PE = Aus-
schlusschance) beider Ansätze zur Blutgruppenbildung wurden 
verglichen. Ergebnisse: Die Prävalenz der großen AB0-Allele und 
-Genotypen korrespondierte mit dem erwarteten Auftreten der 
AB0-Blutgruppen in einer europäischstämmigen Population. Die 
niedrig auf lösende Genotypisierung von 4 diallelen Markern 
ergab eine korrekte Genotyp-Phänotyp-Korrelation bei 1331 der 
1335 Proben (99,7%). Bei 60 Vaterschafts-Trios mit bestätigter 
 Vaterschaft des vermeintlichen Vaters auf der Basis einer STR-
Analyse waren sowohl die PL als auch die PE des AB0-Genotyps 
deutlich höher als die des AB0-Phänotyps. In 12 von 35 Aus-
schlussfällen (34,3%) schloss der AB0-Genotyp auch den ver-
meintlichen Vater aus, während dies beim AB0-Phänotyp nur in 
7 Fällen (20%) möglich war. Schlussfolgerung: Bei der Vater-
schaftstestung war die AB0-Genotypisierung der AB0-Phänotypi-
sierung in Hinblick auf PL und PE überlegen; allerdings war auch 
die AB0-Genotypisierung nicht ausreichend für eine valide Vater-
schaftstestung. Aufgrund der weit geringeren Mutationsrate im 
Vergleich zu STR-Markern könnten Blutgruppen-SNPs zusätzlich 
zu anonymen SNPS bei zukünftigen Verwandtschaftsanalysen 
und Testungen der genetischen Identität miteinbezogen werden.
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Material and Methods
Anonymous DNA Bank of Blood Donors
The geographical origin of blood donors of our transfusion service is the 
southwestern part of Germany. A DNA bank was established as a repre-
sentative sample of our blood donor cohort and encompasses 1,335 blood 
donors with a mean age of 46.8 ± 15.3 years (range 18.0–68.8 years) and 1:1 
gender distribution. Data about ABO blood groups were taken from the 
blood donor files. All donors had regular ABO blood groups. Donors gave 
written consent to provide blood samples for research purposes. The DNA 
bank was established with anonymous sample coding without the possibil-
ity of de-coding. The anonymous DNA bank was approved by the ethics 
committee of the Heidelberg University, Medical Faculty Mannheim. 
DNA Isolation and Standard ABO Genotyping by PCR-SSP
DNA was isolated from buffy coats of CPD-anticoagulated whole blood do-
nations using a commercial system (FlexiGene DNA Kit; Qiagen, Hilden, 
Germany). For ABO blood group genotyping the ABO gene polymor-
phisms 261G>del (for deletional O alleles), 802G>A (for the non-deletional 
O allele *O03), 803G>C (for B alleles), and 1061C>del (for A2 alleles) were 
analyzed in all samples by PCR with sequence specific primers (PCR-SSP) 
as described previously [11]. The alleles were detected by 8 separate reac-
tions each with allele-specific and internal control primers. According to an 
optimized protocol only 5 ng DNA were used per reaction [12]. In this low-
resolution genotyping approach rare variants with mutations at other sites 
of the ABO gene are not recognized. Exclusion of the four variant alleles 
261del, 802A, 803C, and 1061del indicated the A1 blood group.
Serologic ABO Blood Grouping
ABO blood groups A1, A2, B and O were determined using lectins and 
monoclonal antisera (Optima GmbH, Bammental, Germany) in standard 
hemagglutination tests.
Statistical Analysis
Basic statistical analysis including observed heterozygosity, polymorphic 
information content (PIC), power of discrimination (PD), PE, and Hardy-
Weinberg equilibrium test was performed using the PowerStatsV12 Excel 
workbook template developed and provided by Promega Corp. (Promega 
GmbH, Mannheim, Germany) and the statistical software package SPSS 
(Version 12.0; SPSS Inc., Chicago, IL, USA).
Results
PCR-SSP-based genotyping for the ABO polymorphisms 
261G>del, 802G>A, 803G>C and 1061C>del was performed 
on 1,335 samples of an anonymized blood donor DNA bank. 
Unambiguous results could be obtained for all samples (table 
2). Each of the 4 polymorphisms fulfilled the Hardy-Weinberg 
Introduction
After the discovery of the Mendelian inheritance of the ABO 
blood group system by von Dungern and Hirschfeld in 1910 
[1], blood group phenotyping including further systems has 
been introduced to paternity investigation [2]. For more than 
60 years investigation of blood group systems and the HLA 
system represented the standard in forensic genetics. This se-
rological era was then replaced by molecular genetics through 
the introduction of DNA fingerprints first on the basis of min-
isatellite (i.e. variable number of tandem repeat; VNTR) pol-
ymorphisms, later by the analysis of microsatellite (i.e. short 
tandem repeats; STR) polymorphisms [3]. Recent efforts led 
to the introduction of single nucleotide polymorphism (SNP) 
typing for human identification [4]. 
The ABO gene is located on the long arm of human chro-
mosome 9 and consists of 7 exons. Exons 6 and 7 encode the 
major proportion including the catalytic domain of the glyco-
syltransferases that mediate the expression of A and B anti-
gens [5, 6]. A number of studies have shown a clear genotype-
phenotype correlation [7–9], and more than 240 gene variants 
are listed in the open access database dbRBC at the NCBI 
website [10]. Most of the gene variants are characterized by 
one or more SNPs leading to amino acid changes or stop co-
dons. In addition, some variants result from nucleotide inser-
tions or deletions (indels) mostly leading to a frame shift of 
the reading frame and subsequent alteration of the encoded 
amino acid sequence. The ABO blood groups A1, A2, and B 
result from the wild type allele ABO*A101 and the major 
variant alleles ABO*A201, and ABO*B101. The O pheno-
type is mostly caused by deletional O alleles such as 
ABO*O01 or ABO*O02 each characterized by the indel pol-
ymorphism 261G>del in exon 6. The most common non-dele-
tional O allele is ABO*O03 with a point mutation in exon 7 
also leading to the O phenotype (table 1). 
In the present study we determined the frequencies of the 
major ABO alleles in a representative German population by 
using PCR with sequence-specific primers (PCR-SSP). We 
then used serologic and genetic ABO blood grouping in pa-
ternity trios (child, mother, alleged father) in order to com-
pare paternity likelihood (PL) and power of exclusion (PE) of 
both blood grouping approaches.
Allele Phenotype Exon 6 Exon 7
261 297 467 526 657 703 796 802 803 930 1,061
A101 (wt) A1 G A C C C G C G G G C
A201 A2 – – T – – – – – – – del
B101 B – G – G T A A – C A –
O01 O del – – – – – – – – – –
O03 O – G – G – – – A – – –
– = No difference to the wild type (wt) allele *A101; italic letters/numbers indicate the gene polymorphisms used for ABO 
blood group genotyping in the present study.
Table 1. DNA se-
quence characteristics 
in exon 6 and 7 of the 
major ABO alleles
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sponding blood group O genotype. In the remaining 4 sam-
ples the low-resolution genotyping approach indicated blood 
group A (O01/A1). It is assumed that in these samples rare 
variants (Var), i.e. O alleles with mutations at other sites of 
the ABO gene, are present. We therefore classified the geno-
type of the 4 samples as O01/Var, and the frequency of Var 
was 0.15% (4 of 2,670 alleles) in our cohort. In summary, 
1,331 of 1,335 (99.7%) blood groups were correctly deter-
mined from the low-resolution ABO genotype. Based on the 
observed allele frequencies (O01, 0.5955; A1, 0.2176; B, 
0.1004; A2, 0.0637; O03, 0.0213; Var, 0.0015) we calculated 
statistical parameters: i) observed heterozygosity = 0.5775; ii) 
PIC = 0.5380; iii) PD = 0.7803; iv) PE = 0.2648.
To further evaluate the impact of the ABO genotype in 
kinship analysis, we performed the low-resolution ABO geno-
typing and ABO phenotyping (A1, A2, B, and O) in 95 pater-
nity trio cases (child, mother, alleged father). Previously, pa-
ternity of the alleged father was determined on the basis of 
STR analysis including 12 markers (D3S1358, D7S820, 
D13S317, D16S539, D18S51, D21S11, CSF1PO, FGA, Pen-
taE, PentaD, TH01, TPOX). Paternity was excluded in 35 
cases and confirmed in 60 cases. In 23 of the 35 excluded pa-
ternities (65.7%) neither the ABO genotype nor the ABO 
phenotype enabled exclusion of the alleged father. In 7 cases 
(20%) both ABO genotype and phenotype confirmed exclu-
sion of the alleged father. In the remaining 5 cases (14.3%) 
the ABO genotype, but not the ABO phenotype, enabled ex-
clusion of the alleged father (table 4).
In the 60 cases with confirmed paternity, both PL and PE 
of the ABO genotype was significantly higher than those of 
the ABO phenotype (table 5). Only in three cases where the 
child’s ABO phenotype was B and the mother’s phenotype 
was A or O the PE of the ABO genotype was slightly lower 
compared to the ABO phenotype (80.9% vs. 84.8%). In sum-
mary, the ABO genotype was superior to the ABO phenotype 
in all 95 paternity trio cases.
Discussion
In our study we determined the prevalence of the major ABO 
gene variants in a population of German blood donors. Four 
diallelic markers were determined by PCR-SSP with opti-
mized sensitivity in order to reduce DNA consumption [12]. 
The ABO genotype could be obtained from less than 50 ng 
genomic DNA. However, the impact of DNA degradation on 
ABO genotyping by PCR-SSP has not been investigated so 
far. The genotypes were used to deduce the corresponding 
ABO blood group phenotype, and we found 99.7% genotype-
phenotype correlation for our low-resolution genotyping ap-
proach. The frequency of the different blood groups in our 
cohort corresponded to the expected frequencies (A 43%; B 
9%; AB 4%; O 44%) for Caucasian populations [13]. Thus, 
we conclude that our study cohort is a representative sample 
equilibrium. The 261del variant characteristic for the majority 
of O alleles was the most prevalent variant of the ABO gene 
(1,590 of 2,670 alleles; 59.6%). Absence of all four variants 
indicated the presence of the wild type A1 allele. However, 
mutations at other sites of the ABO gene cannot be excluded 
by the low-resolution genotyping. 
In order to determine the specificity of the low-resolution 
genotyping approach we compared the ABO blood group 
phenotype (A, B, AB, or O) registered in the blood donor 
files with the determined genotype. Blood groups A, B, and 
AB revealed a 100% phenotype/genotype correlation with 
the different genotypes (table 3). For 519 of the 523 samples 
(99.2%) with blood group O, we could determine a corre-
Table 2. Observed ABO allele frequencies and resulting statistical pa-
rameters in the study cohort of 1,335 German blood donors
Gene variant Deduced  
allele
Numbers of alleles  
(n = 2,670)
Allele  
frequency
261del O01 1,590 0.5955
802A O03 57 0.0213
803C B 268 0.1004
1061del A2 170 0.0637
wt* A1 581 0.2176
Various Var 4 0.0015
*Wild type (wt) allele A1 was present when no variant allele was  
identified.
Table 3. Phenotype-genotype correlation for the low resolution ABO 
genotyping
ABO phenotype ABO  
genotypes
Numbers of genotypes  
(n = 1,335)
Percentage of  
genotypes*
A  
(n = 555; 41.6%)
O01/A1 
O01/A2 
A1/A1 
A2/A1 
O03/A1 
O03/A2 
A2/A2 
all
335 
 93 
 66 
 47 
  6 
  6 
  2 
555
60.4 
16.8 
11.9 
8.5 
1.1 
1.1 
0.4 
100.0
O  
(n = 523; 39.2%)
O01/O01 
O01/O03 
O03/O03 
all 
O01/A1
484 
 34 
  1 
519 
  4
92.5 
6.5 
0.2 
99.2 
0.8
B  
(n = 176; 13.2%)
O01/B 
B/B 
O03/B 
all
156 
  11 
  9 
176
88.6 
6.3 
5.1 
100.0
AB  
(n = 81; 6.1%)
A1/B 
A2/B 
all
 61 
 20 
 81
75.3 
24.7 
100.0
*Given as percentage of the corresponding phenotype; italic letters  
indicate samples with discrepancy between phenotype and genotype.
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ABO alleles could even strengthen this finding; however, 
analysis of further SNPs would be necessary to identify such 
alleles. The O02 allele is a common variant of the O01 allele 
carrying the indel polymorphism 261G>del in exon 6 and nine 
additional nucleotide changes in exons 2–7. It was shown that 
the O02 allele accounts for approximately 40% of O alleles 
[14]. The differential typing for O01 and O02 alleles would 
further enhance the statistical power of ABO genotyping, but 
was not performed in this study. Using a theoretical allele fre-
quency of 0.41 of the O01 and 0.18 of the O02 allele in our 
population and assuming Hardy-Weinberg equilibrium for all 
alleles we re-calculated the statistical parameters. Discrimina-
tion of O01 and O02 alleles further increased the observed 
heterozygosity to 0.6856 (before 0.5775), PIC to 0.7025 (be-
fore 0.5380), PD to 0.8925 (before 0.7803), and PE to 0.4064 
(before 0.2648). These values are similar to those reported in 
ABO genotyping of a small (n = 60) Italian cohort [15]. We 
assume that discrimination between the O01 and O02 alleles 
is reasonable and could be performed by typing a further SNP 
such as 646T>A or 681G>A in exon 7 of the ABO gene.
Typing of highly polymorphic STR markers is the current 
worldwide standard in kinship analysis and forensic case 
work. The high PD and PE for each STR marker enable a re-
liable determination of paternity. Other marker systems such 
as blood groups, HLA, or RFLPs became uncomely due to 
the lower statistical power and higher labor input. However, 
the reasonable mutation rates of up to 1% of each STR 
of the German population. In 4 of 1,335 samples (0.3%) with 
O phenotype but O01/A1 genotype we proposed rare variant 
alleles. Sequence analysis of the entire ABO gene confirmed 
rare alleles such as Aw13 and O51 (data not shown). Most of 
the alleles stored in the dbRBC database represent rare ABO 
alleles characterized by point mutations in different exons of 
the ABO gene. Many variant alleles have a phenotypic equiv-
alent such as weak expression of A or B antigens or blood 
group O. The genotype-phenotype correlation could be en-
hanced by investigating more of the rare variants. 
We demonstrated that PL and PE of the ABO genotype is 
superior to the ABO phenotype. The inclusion of additional 
Case ABO phenotype Essential paternal feature  
(PE%)*
ABO genotype Essential paternal feature  
(PE%)
1
 C 
 M 
 AF
A1
A1
O
all (0%) A1/A1 
O01/A1 
O01/O01
A1 (61.22%)
2
 C 
 M 
 AF
A1
A1B
O
all (0%) A1/A1 
A1/B 
O01/O01
A1 (61.31%)
3
 C 
 M 
 AF
A1
A1
O
all (0%) A1/A1 
O01/A1 
O01/O01
A1 (61.22%)
4
 C 
 M 
 AF
A1
A1
O
all (0%) A1/A1 
O01/A1 
O01/O01
A1 (61.22%)
5
 C 
 M 
 AF
A2
O 
A1
A2 (54.65%) O01/A2 
O01/O01 
O01/A1
A2 (87.61%)
C = Child; M = mother; AF = alleged father.
*PE, power of exclusion; in cases with the dominant phenotype A1 for child and mother all paternal blood groups are 
possible (no exclusion).
Table 4. Five pater-
nity trio cases in 
which the ABO geno-
type but not the 
ABO phenotype 
 enabled exclusion of 
the alleged father
Table 5. Paternity likelyhood and exclusion power of the ABO pheno-
type and the ABO genotype in 60 trios with confirmed paternity
ABO phenotype ABO genotype p value*
Paternity likelyhood
 Range 38.2–90.0% 38.1–96.0%
 Median 61.1% 62.7%
 Mean ± SD 61.4 ± 13.2% 64.8 ± 12.4% 0.0214
Power of exclusion
 Range 0–84.8% 3.5–95.8%
 Median 4.5% 16.4%
 Mean ± SD 21.8 ± 28.9% 35.3 ± 29.5% <0.0001
*Statistical significance of the differences between phenotype and geno-
type calculated by pairwise t-tests.
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our laboratory, ABO phenotyping and genotyping is validated 
for clinical diagnostics and paternity testing, and the procedure 
is defined in standard operation protocols. The same is true for 
other blood group systems such as Duffy, MNS, Kidd, and Kell. 
Low-resolution ABO genotyping by PCR-SSP method includ-
ing agarose gel electrophoresis is a very time- (less than 2 h; 
many samples simultaneously) and cost-effective method (less 
than EUR 2.– per DNA sample). In paternity cases or any 
other forensic case work DNA samples for STR analysis can 
also be used for SNP typing. Using PCR-SSP with optimized 
sensitivity [12], genotyping requires less than 10 ng DNA per 
SNP and can be performed on DNA extracted from buccal 
swaps. Other SNP genotyping methods including multiplex 
PCR with capillary electrophoresis [17] or other procedures 
[18] would require even lower DNA amounts. 
Finally, for the development of systems for genetic identity 
testing based on diallelic markers, we would recommend to 
combine anonymous SNPs and SNPs associated with an easy-
to-determine phenotype such as blood groups or HLA. This 
could open a new field of clinical application of genetic iden-
tity testing, e.g. where the identity of a hematopoietic stem 
cell transplant shipped from the donation site to the trans-
plantation center is rechecked.
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marker could hamper result interpretation [16]. The mutation 
rate per meiosis of diallelic markers including SNPs is esti-
mated to be 100,000 times lower compared to STRs. There-
fore, the reliability of SNP-based kinship analysis is higher 
and could probably replace STR-based analysis in future. By 
using ABO blood grouping in paternity trio cases we could 
show that ABO genotyping is superior to phenotyping with 
regard to statistical parameter such as PL and PE. In 12 of 
35 trios (34.3%) where paternity was excluded by at least 5 of 
12 STR markers, the ABO genotype also excluded paternity. 
The ABO phenotype could exclude paternity in only 20% of 
the cases. However, we must point out that neither ABO gen-
otyping nor ABO phenotyping is sufficient for valid paternity 
testing. It should be regarded as an supplementary and op-
tional approach to add further value to paternity cases based 
on STR systems. 
Since the discovery of SNPs as the genetic basis of the 
ABO and of many other blood groups, SNP typing could 
probably bring back blood grouping to paternity testing on a 
molecular genetic basis. For this purpose the genotype-pheno-
type correlation is an important prerequisite and has been 
demonstrated for many different blood group systems includ-
ing ABO, Rh, Duffy, MNS, Kidd, and Kell. Identification of 
individuals using anonymous SNPs on different chromosomes 
such as the SNPforID markers [4] could be combined with 
SNPs of different blood group systems. In selected cases and 
in terms of control purposes, i.e. to match a blood sample with 
a DNA sample, the phenotypes of blood groups on different 
chromosomes could provide useful information. Phenotyping 
and genoytping of HLA antigens could be used as well. 
The application of SNP typing in a routine laboratory such 
as clinical diagnostics or paternity testing requires proof of reli-
ability of the method and standardization of the procedure. In 
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